Powerful stuff. In my 20 years of marketing I have never seen such valuable data on my drug brands.
Specialist Team Leader, Pfizer Limited
It provides a level of insight which has been difficult to obtain using existing tools. The team was impressed by its ability to predict market share movements based on mix investment decisions.
Brand Manager, GlaxoSmithKline
At InfoMedics, we find this an invaluable reference guide when engaged in strategic planning work with Pharmaceutical customers. I am of the strong opinion that readers of this report will be significantly wiser after reading it and better armed to design effective and profitable adherence strategies for their companies.
Michael R. Ball, Ph.D, VP Marketing and Product Management, InfoMedics Inc.
Eularis …. the only Pharmaceutical analytics firm I rate as worth the investment
Head of Business Analytics, Merck
This report provided an excellent overview of all aspects of E-Detailing and supported the development of a pilot for my organization.
eBusiness Manager, Strategic Development Department, Pfizer